To investigate the effects which a non-functional circadian clock has on IBD, Bmal1+/+ controls and Bmal1-/- mutants were treated with DSS, and their recovery tracked for an additional 10 days. This evidence concerns the gene BMAL1 and inflammatory bowel disease.